• COVID-19 Standard Operating Procedures (SOPs) for Return to Laboratories and Research
• Research Protocol for Home Research Visits as part of Research Studies
• COVID-19 Commitment to Public Health Form
• Introduction to Scholarly Publishing for Researchers
• Tulane FAQs for Federal Grant Applicants and Award Recipients During the COVID-19 Pandemic

Federal grant funding details related to COVID-19:

• NIH/NSF Grant Funding Flexibility
• NIH Resource to Analyze COVID-19 Literature: The COVID-19 Portfolio Tool

Information and Resources for Researchers:

Funding opportunities related to COVID-19:

• NIH: Funding Opportunities Related to COVID-19
• NSF Rapid Response proposals:https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.pdf
• MIT: Health Security and Pandemics Challenge ($1 million) Solution pitch due 6.18.2020
• NSF: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) https://www.nsf.gov/pubs/2020/nsf20055/nsf20055.jsp
• DARPA encourages performers with research project ideas related to COVID-19 to respond to the Office-wide broad agency announcements (BAAs) for both the Defense Sciences Office (DSO) and Biological Technology Office (BTO), which both have open BAAs that can receive submissions at any time. The DSO and BTO Office-wide BAAs can be found at https://www.darpa.mil/work-with-us/office-wide-broad-agency-announcements
• HHS/Biomedical Advanced Research and Development Authority (BARDA)
  • BARDA opened an easy broad agency announcement, an EZ-BAA, seeking diagnostics that utilize platforms already cleared by the FDA, with a viable plan to meet requirements for the FDA to consider emergency use authorization within 12 weeks.
• AHRQ: Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19
• NSF: On March 25, NSF released a Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19. The DCL highlights the following areas of research: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. The DCL is available at https://www.nsf.gov/pubs/2020/nsf20065/nsf20065.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
• Russel Sage Foundation:  Funds to study social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States;  https://www.russellsage.org/how-to-apply/application-deadlines
• DOD: Newton Award https://www.grants.gov/web/grants/view-opportunity.html?oppId=326034
• CDMRP:
  • Clinical Trial Award (for Emerging Viral Diseases and Respiratory Health)
  • Investigator-Initiated Research Award (for Emerging Viral Diseases and Respiratory Health)
  • Technology/Therapeutic Development Award (for Emerging Viral Diseases and Respiratory Health)
• AHA: https://www.lung.org/getmedia/9ff5f39f-ca59-44cb-ace1-96f0df4a7687/covid-19-and-emerging-respiratory-viruses-research-rfp-w-award-application-guide.pdf
• NIH/NHLBI: https://www.nhlbi.nih.gov/sites/default/files/media/docs/COVID19-ROA-OTA-FINAL.pdf
• NEH: https://www.neh.gov/program/neh-cares-cultural-organizations
• American Diabetes Association (ADA): https://professional.diabetes.org/sites/professional.diabetes.org/files/media/ada-covid-19_rfa_.pdf

NOTICES:

• Tulane FAQs for Federal Grant Applicants and Award Recipients During the COVID-19 Pandemic
• The AHA announced that its collaboration with Lawrence Livermore National Labs on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help speed discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19. A searchable data portal is now available.

Sponsor Guidance for federal applicants and grantees:

• NIH https://grants.nih.gov/grants/natural_disasters/corona-virus.htm
  • Information for NIH Applicants and Recipients of NIH Funding Related to COVID-19
  • NIH FAQs: COVID-19 Flexibilities for Applicants and Recipients
• NSF:  https://www.nsf.gov/news/special_reports/coronavirus/
• NEA: https://www.arts.gov/coronavirus
• NEH: https://www.neh.gov/news/information-neh-and-covid-19
• DOE: https://www.energy.gov/coronavirus-hub
• DOE:  Implementation of OMB Memorandum M-20-17
  • DoEd: https://www.ed.gov/coronavirus?src=feature
• DOJ:  Sends you to CDC: https://www.coronavirus.gov/
• OMB: Sends you to CDC; https://www.coronavirus.gov/
• LaBOR: https://regents.la.gov/covid19-response/
• DOD: https://basicresearch.defense.gov/COVID-19/Frequently-Asked-Questions/
• AFOSR: https://afresearchlab.com/afosr-covid
• AHRQ:  https://grants.nih.gov/grants/guide/notice-files/NOT-HS-20-010.html
• NOAA: https://www.noaa.gov/organization/acquisition-grants/news/health-and-safety-information-for-financial-assistance
• CDC: https://www.cdc.gov/grants/public-health-emergencies/covid-19/flexibilities-available-applicants-recipients/index.html
• NASA: “SMD FAQ on Grants and Research during the COVID-19 Epidemic” - link: https://science.nasa.gov/science-red/s3fs-public/atoms/files/NASACOVIDFAQ033120.pd
• NASA: "COVID-19 and Federal Financial Assistance" - Link: https://science.nasa.gov/science-red/s3fs-public/atoms/files/COVID-19%20and%20Federal%20Financial%20Assistance.pdf

Tulane University Guidance for Researchers during the COVID-19 Pandemic March 24, 2020

Tulane virologist Dr. Robert Garry explains origins of COVID-19

COVID-19 Public Town Hall: Tulane University School of Medicine

Comprehensive summary of federal guidance and funding opportunities